Deutsche Märkte öffnen in 3 Stunden 51 Minuten

Koninklijke Philips N.V. (PHIA.AS)

Amsterdam - Amsterdam Verzögerter Preis. Währung in EUR
Zur Watchlist hinzufügen
18,69-0,17 (-0,91%)
Börsenschluss: 05:35PM CET

Koninklijke Philips N.V.

Philips Center
Amstelplein 2
Amsterdam 1096 BC
31 20 597 7777

BrancheMedical Devices

Leitende Angestellte

Mr. Roy JakobsPresident, CEO & Chairman of the Board of Management1,28MN/A1974
Dr. Paulus A. Stoffels M.D., Ph.D.Independent Vice Chairman of Supervisory Board & Secretary177,27kN/A1962
Mr. Abhijit BhattacharyaExecutive VP, CFO & Member of the Board of Management1,13M485,44k1961
Mr. Marnix J. van GinnekenExecutive VP, Chief ESG, Legal Officer & Member of the Board of Management831,35k244,75k1973
Mr. Willem AppeloExecutive VP & COON/AN/A1965
Mr. Leandro MazzoniHead of Investor RelationsN/AN/AN/A
Ms. Daniela SeabrookExecutive VP & Chief Human Resources OfficerN/AN/A1973
Mr. Andy HoExecutive VP & Chief Market Leader of Philips Greater ChinaN/AN/A1961
Jan KimpenChief Medical OfficerN/AN/A1958
Mr. Pim PreesmanCountry Leader/ Health Systems Leader IndonesiaN/AN/AN/A
Die Beträge haben den Stand 31. Dezember 2022 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in EUR.


Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. It operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. The company provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease; proprietary software to enable diagnostics and intervention; and enterprise diagnostic informatics products and services. It also offers acute patient management solutions; emergency care solutions; sleep and respiratory care solutions; and electronic medical record and care management solutions. In addition, the company provides power toothbrushes, brush heads, and interdental cleaning and teeth whitening products; infant feeding, baby monitors, and digital parental solutions; and grooming and beauty products and solutions. It has strategic partnership agreements with TriHealth, Prisma Health, and the University Health System of San Antonio to help the health system standardize patient monitoring, drive interoperability, and lay the foundation for enterprise-wide platform; and Oulu University Hospital to deliver advanced image-guided therapy solutions. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.

Corporate Governance

Koninklijke Philips N.V.s ISS Governance QualityScore, Stand 1. Februar 2024, lautet 3. Die grundlegenden Scores sind Audit: 1, Vorstand: 1, Shareholderrechte: 5, Kompensation: 6.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.